PD2/PAF1 at the crossroads of the cancer network

Saswati Karmakar, Parama Dey, Arokia P. Vaz, Sukesh R. Bhaumik, Moorthy Palanimuthu Ponnusamy, Surinder Kumar Batra

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Pancreatic differentiation 2 (PD2)/RNA polymerase II–associated factor 1 (PAF1) is the core subunit of the human PAF1 complex (PAF1C) that regulates the promoter-proximal pausing of RNA polymerase II as well as transcription elongation and mRNA processing and coordinates events in mRNA stability and quality control. As an integral part of its transcription-regulatory function, PD2/PAF1 plays a role in posttranslational histone covalent modifications as well as regulates expression of critical genes of the cell-cycle machinery. PD2/PAF1 alone, and as a part of PAF1C, provides distinct roles in the maintenance of self-renewal of embryonic stem cells and cancer stem cells, and in lineage differentiation. Thus, PD2/PAF1 malfunction or its altered abundance is likely to affect normal cellular functions, leading to disease states. Indeed, PD2/PAF1 is found to be upregulated in poorly differentiated pancreatic cancer cells and has the capacity for neoplastic transformation when ectopically expressed in mouse fibroblast cells. Likewise, PD2/PAF1 is upregulated in pancreatic and ovarian cancer stem cells. Here, we concisely describe multifaceted roles of PD2/PAF1 associated with oncogenic transformation and implicate PD2/PAF1 as an attractive target for therapeutic development to combat malignancy.

Original languageEnglish (US)
Pages (from-to)313-319
Number of pages7
JournalCancer Research
Volume78
Issue number2
DOIs
StatePublished - Jan 15 2018

Fingerprint

Neoplastic Stem Cells
Pancreatic Neoplasms
Histone Code
cdc Genes
RNA Polymerase II
RNA Stability
Cell Lineage
DNA-Directed RNA Polymerases
Embryonic Stem Cells
Quality Control
Ovarian Neoplasms
Neoplasms
Fibroblasts
Messenger RNA
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

PD2/PAF1 at the crossroads of the cancer network. / Karmakar, Saswati; Dey, Parama; Vaz, Arokia P.; Bhaumik, Sukesh R.; Palanimuthu Ponnusamy, Moorthy; Batra, Surinder Kumar.

In: Cancer Research, Vol. 78, No. 2, 15.01.2018, p. 313-319.

Research output: Contribution to journalReview article

Karmakar, Saswati ; Dey, Parama ; Vaz, Arokia P. ; Bhaumik, Sukesh R. ; Palanimuthu Ponnusamy, Moorthy ; Batra, Surinder Kumar. / PD2/PAF1 at the crossroads of the cancer network. In: Cancer Research. 2018 ; Vol. 78, No. 2. pp. 313-319.
@article{b92ab3a71b66441eb0ff7f7d83024ea3,
title = "PD2/PAF1 at the crossroads of the cancer network",
abstract = "Pancreatic differentiation 2 (PD2)/RNA polymerase II–associated factor 1 (PAF1) is the core subunit of the human PAF1 complex (PAF1C) that regulates the promoter-proximal pausing of RNA polymerase II as well as transcription elongation and mRNA processing and coordinates events in mRNA stability and quality control. As an integral part of its transcription-regulatory function, PD2/PAF1 plays a role in posttranslational histone covalent modifications as well as regulates expression of critical genes of the cell-cycle machinery. PD2/PAF1 alone, and as a part of PAF1C, provides distinct roles in the maintenance of self-renewal of embryonic stem cells and cancer stem cells, and in lineage differentiation. Thus, PD2/PAF1 malfunction or its altered abundance is likely to affect normal cellular functions, leading to disease states. Indeed, PD2/PAF1 is found to be upregulated in poorly differentiated pancreatic cancer cells and has the capacity for neoplastic transformation when ectopically expressed in mouse fibroblast cells. Likewise, PD2/PAF1 is upregulated in pancreatic and ovarian cancer stem cells. Here, we concisely describe multifaceted roles of PD2/PAF1 associated with oncogenic transformation and implicate PD2/PAF1 as an attractive target for therapeutic development to combat malignancy.",
author = "Saswati Karmakar and Parama Dey and Vaz, {Arokia P.} and Bhaumik, {Sukesh R.} and {Palanimuthu Ponnusamy}, Moorthy and Batra, {Surinder Kumar}",
year = "2018",
month = "1",
day = "15",
doi = "10.1158/0008-5472.CAN-17-2175",
language = "English (US)",
volume = "78",
pages = "313--319",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "2",

}

TY - JOUR

T1 - PD2/PAF1 at the crossroads of the cancer network

AU - Karmakar, Saswati

AU - Dey, Parama

AU - Vaz, Arokia P.

AU - Bhaumik, Sukesh R.

AU - Palanimuthu Ponnusamy, Moorthy

AU - Batra, Surinder Kumar

PY - 2018/1/15

Y1 - 2018/1/15

N2 - Pancreatic differentiation 2 (PD2)/RNA polymerase II–associated factor 1 (PAF1) is the core subunit of the human PAF1 complex (PAF1C) that regulates the promoter-proximal pausing of RNA polymerase II as well as transcription elongation and mRNA processing and coordinates events in mRNA stability and quality control. As an integral part of its transcription-regulatory function, PD2/PAF1 plays a role in posttranslational histone covalent modifications as well as regulates expression of critical genes of the cell-cycle machinery. PD2/PAF1 alone, and as a part of PAF1C, provides distinct roles in the maintenance of self-renewal of embryonic stem cells and cancer stem cells, and in lineage differentiation. Thus, PD2/PAF1 malfunction or its altered abundance is likely to affect normal cellular functions, leading to disease states. Indeed, PD2/PAF1 is found to be upregulated in poorly differentiated pancreatic cancer cells and has the capacity for neoplastic transformation when ectopically expressed in mouse fibroblast cells. Likewise, PD2/PAF1 is upregulated in pancreatic and ovarian cancer stem cells. Here, we concisely describe multifaceted roles of PD2/PAF1 associated with oncogenic transformation and implicate PD2/PAF1 as an attractive target for therapeutic development to combat malignancy.

AB - Pancreatic differentiation 2 (PD2)/RNA polymerase II–associated factor 1 (PAF1) is the core subunit of the human PAF1 complex (PAF1C) that regulates the promoter-proximal pausing of RNA polymerase II as well as transcription elongation and mRNA processing and coordinates events in mRNA stability and quality control. As an integral part of its transcription-regulatory function, PD2/PAF1 plays a role in posttranslational histone covalent modifications as well as regulates expression of critical genes of the cell-cycle machinery. PD2/PAF1 alone, and as a part of PAF1C, provides distinct roles in the maintenance of self-renewal of embryonic stem cells and cancer stem cells, and in lineage differentiation. Thus, PD2/PAF1 malfunction or its altered abundance is likely to affect normal cellular functions, leading to disease states. Indeed, PD2/PAF1 is found to be upregulated in poorly differentiated pancreatic cancer cells and has the capacity for neoplastic transformation when ectopically expressed in mouse fibroblast cells. Likewise, PD2/PAF1 is upregulated in pancreatic and ovarian cancer stem cells. Here, we concisely describe multifaceted roles of PD2/PAF1 associated with oncogenic transformation and implicate PD2/PAF1 as an attractive target for therapeutic development to combat malignancy.

UR - http://www.scopus.com/inward/record.url?scp=85040565058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85040565058&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-17-2175

DO - 10.1158/0008-5472.CAN-17-2175

M3 - Review article

VL - 78

SP - 313

EP - 319

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 2

ER -